Jeremy Levin has seen the biopharma industry from practically every vantage point. Now, with decades of experience under his belt, he’s out front in the chorus of veterans sounding the alarm about threats to US dominance in biotech. He joins Post-Hoc Live to talk about China, US policy, and how to stem the bleeding.  Stay ahead of biopharma. Get the Main Edition in your inbox M-F at 11:30 AM ET. Sign up: <a href="https://shorturl.at/OBB3D">https://shorturl.at/OBB3D</a>

Jeremy Levin has seen the biopharma industry from practically every vantage point. Now, with decades of experience under his belt, he’s out front in the chorus of veterans sounding the alarm about threats to US dominance in biotech. He joins Post-Hoc Live to talk about China, US policy, and how to stem the bleeding. Stay ahead of biopharma. Get the Main Edition in your inbox M-F at 11:30 AM ET. Sign up: https://shorturl.at/OBB3D

Jeremy Levin has seen the biopharma industry from practically every vantage point. Now, with decades of experience under his belt, he’s out front in the chorus of veterans sounding the alarm about threats to US dominance in biotech. He joins Post-Hoc Live to talk about China, US policy, and how to stem the bleeding.&nbsp; Stay ahead of biopharma. Get the Main Edition in your inbox M-F at 11:30 AM ET. Sign up: <a href="https://shorturl.at/OBB3D" rel="noopener noreferrer">https://shorturl.at/OBB3D</a>

How to stabilize US biotech — with Dr. Jeremy Levin

Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations.

Subscribe to Endpoints and the Post-Hoc newsletter here: https://profile.endpoints.news/create-account. Send us an email at: posthoclive@endpointsnews.com

News

Post-Hoc Live is an extension of Endpoints' analysis newsletter Post-Hoc — but streamed live on YouTube then brought to you here. Our reporters spend every day texting and calling sources, reading executive orders, and talking to each other in Slack. We're bringing that analysis that happens behind the scenes directly to you, and letting you in on some of our up-to-the-moment conversations. Subscribe to Endpoints and the Post-Hoc newsletter here: https://profile.endpoints.news/create-account. Send us an email at: posthoclive@endpointsnews.com

Share How to stabilize US biotech — with Dr. Jeremy Levin

Sign up to save your podcasts

How to stabilize US biotech — with Dr. Jeremy Levin

How to stabilize US biotech — with Dr. Jeremy Levin

More shows like Post-Hoc Live

Freakonomics Radio

Planet Money

99% Invisible

Odd Lots

Nature Podcast

The Daily

Up First from NPR

The Readout Loud

Wall Street Breakfast

The Journal.

Morning Brew Daily

All-In with Chamath, Jason, Sacks & Friedberg

BioCentury This Week

No Priors: Artificial Intelligence | Technology | Startups

The BioCentury Show